Uroflow Measurements in Urogynecology Patients Compared to Healthy Female

See also
Status	Clinical Trial	Phase
Completed	`NCT00757484` - Evaluation of Postoperative Blood Pressure Changes After Benign Gynecologic Surgery	N/A
Completed	`NCT00757432` - Recovery After Robotic Urogynecological Surgery: The Patient's Perspective	N/A
Completed	`NCT01033786` - Robotic Urogynecological Surgery: Hospital Stay and Perioperative Complications
Recruiting	`NCT05885958` - Timing of Active Void Trials After Urogynecologic Procedures	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT00757484 - Evaluation of Postoperative Blood Pressure Changes After Benign Gynecologic Surgery

N/A

Completed

NCT00757432 - Recovery After Robotic Urogynecological Surgery: The Patient's Perspective

N/A

Completed

NCT01033786 - Robotic Urogynecological Surgery: Hospital Stay and Perioperative Complications

Recruiting

NCT05885958 - Timing of Active Void Trials After Urogynecologic Procedures

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00919048
Study type	Observational
Source	University of Rochester
Contact
Status	Completed
Phase	N/A
Start date	September 2008
Completion date	September 2008

Uroflow Measurements in Urogynecology Patients Compared to Healthy Female Volunteers

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms